< Back to search
Filter
1

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma, Refractory Multiple Myeloma,
Location: San Francisco CA
Sponsor: Alfred Chung, MD

Sex: All

Age: 18+

Code: NCT06348108

Phase1, Recruiting

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06940297

Phase2, Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07105059

Phase1, Recruiting

Study of CAR-T Therapy in Older Patients

for
Lymphoma, Refractory B-Cell Lymphoma, Lymphoma, B-Cell,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 60+

Code: NCT04300998

Recruiting

Interested in new multiple myeloma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

for
B-Cell Lymphoma, Myelodysplastic Syndromes (MDS),
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12 - 70+

Code: NCT05092451

Phase1, Phase2, Recruiting

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Birmingham AL
Sponsor: Susan Bal

Sex: All

Age: 19+

Code: NCT07333261

Phase1, Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

for
Myeloma, Multiple Myeloma, Refractory Multiple Myeloma
Location: Boston MA
Sponsor: Omar Nadeem, MD

Sex: All

Age: 18+

Code: NCT06518551

Phase1, Phase2, Recruiting

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

for
Endocrine Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03412877

Phase2, Recruiting

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

for
Smoldering Multiple Myeloma
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05597345

Phase2, Recruiting

Tissue Collection for Studies of Lymph Cancer

for
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01676805

Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Baltimore MD, Bethesda MD, Buffalo NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for
Haematological Malignancy, Acute Myeloid Leukemia,
Location: Philadelphia PA, Bethesda MD, Atlanta GA,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT04068597

Phase1, Phase2, Recruiting

Elranatamab in Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06711705

Phase2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Halifax, Boston MA, New Haven CT, Sherbrooke,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase3, Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Miami FL, Toronto,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase1, Phase2, Recruiting

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Buffalo NY, Tampa FL
Sponsor: Celyad Oncology SA

Sex: All

Age: 18+

Code: NCT03018405

Phase1, Phase2, Recruiting

Host Dendritic Cells in Allograft Patients

for
Relapsed Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18 - 70

Code: NCT00935597

Phase1, Recruiting

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05336383

Phase2, Recruiting